Preloader

Empower™
Hereditary Cancer Panel

Understanding Your Hereditary Cancer Risk Is the First Step Toward Protecting Your Future and the Future of Your Loved Ones.

Empower™ is a comprehensive germline genetic test developed by Natera to evaluate genetic alterations associated with hereditary cancer syndromes. Using a blood sample, the test assesses an individual’s inherited cancer risk, supporting the planning of early detection, screening, and risk management strategies.

Empower™ is used not only for hereditary cancer risk assessment but also to help identify inherited biomarkers that may influence treatment decisions in individuals diagnosed with cancer. In particular, alterations detected in BRCA1, BRCA2, and genes associated with Lynch syndrome may support the evaluation of targeted treatment options.

Identifying genetic variants associated with hereditary cancers enables risk assessment for both individuals and their family members. To provide a more comprehensive molecular profile, Empower™ can also be used alongside somatic genomic profiling tests such as FOCUS CGP veya Altera™ .

Cancer Types:

Breast, Ovarian, Endometrial (Uterine), Colorectal, Gastric, Prostate, Pancreatic, and Melanoma.

FeatureDetails

Who Should Be Tested?

  • Individuals diagnosed with cancer at or before the age of 50;
  • Individuals with a family history of cancer or multiple cancers/tumors on the same side of the family;
  • Individuals concerned about their personal or family history of cancer.

Cancer Type

 Hereditary Cancers

Sample Type

Blood (EDTA Tube)

Method

 Next-Generation Sequencing (NGS)

Coverage

81 Genes

Turnaround Time (TAT)

2–3 Weeks

* Genetic counseling is included as part of this test.
** BRCA1/2 MLPA analysis and the Lynch syndrome panel are included in this test.
*** The panel content can be customized based on clinical findings, family history, and genetic counseling. A detailed gene list is available upon request.

//
Our customer support team is here to answer your questions!